APA

Shokrollahi Barough M., Ashtari F., Sadat Akhavi M., Asghari N., Mosayebi G., Mirmohammadkhani M., Kokhaei N., Bahraminia F., Ajami A. & Kokhaei P. (20190102). Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability. : International immunopharmacology.

Chicago

Shokrollahi Barough Mahdieh, Ashtari Fereshteh, Sadat Akhavi Mehdi, Asghari Nabiollah, Mosayebi Ghasem, Mirmohammadkhani Majid, Kokhaei Naser, Bahraminia Farhad, Ajami Arman and Kokhaei Parviz. 20190102. Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability. : International immunopharmacology.

Harvard

Shokrollahi Barough M., Ashtari F., Sadat Akhavi M., Asghari N., Mosayebi G., Mirmohammadkhani M., Kokhaei N., Bahraminia F., Ajami A. and Kokhaei P. (20190102). Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability. : International immunopharmacology.

MLA

Shokrollahi Barough Mahdieh, Ashtari Fereshteh, Sadat Akhavi Mehdi, Asghari Nabiollah, Mosayebi Ghasem, Mirmohammadkhani Majid, Kokhaei Naser, Bahraminia Farhad, Ajami Arman and Kokhaei Parviz. Neutralizing antibody production against Rebif® and ReciGen® in Relapsing-Remitting Multiple Sclerosis (RRMS) patients and its association with patient's disability. : International immunopharmacology. 20190102.